AdvaMed Comments on OSTP Request for Information: Regulatory Reform on Artificial Intelligence

AdvaMed Submits AI Policy Comments

AdvaMed’s October 27, 2025 submission to the Office of Science and Technology Policy (OSTP) provides detailed recommendations for regulatory reform to promote the adoption and oversight of artificial intelligence in healthcare. The comments highlight the critical role of AI-enabled medical devices in improving patient outcomes, streamlining care delivery, and reducing costs.

The letter emphasizes the need for consistent and clear regulatory frameworks across federal agencies—including the FDA, CMS, and ONC—to ensure that AI innovation advances safely and effectively. AdvaMed also recommends targeted updates to Medicare payment systems, enhanced transparency standards, and improved data privacy policies to facilitate responsible AI development.

As the largest trade association representing medical device and technology manufacturers, AdvaMed continues to advocate for smart, flexible regulations that foster innovation, protect patients, and strengthen U.S. leadership in medical technology.